Lv1
50 积分 2025-07-16 加入
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial
2小时前
待确认
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromes
2个月前
已关闭
Updates in the management of pediatric dyslipidemia
2个月前
已完结
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update
3个月前
已完结
Screening for Lipid Disorders in Children and Adolescents
3个月前
已完结
Familial hypercholesterolaemia: summary of NICE guidance
3个月前
已关闭
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
3个月前
已完结
Lomitapide for the treatment of pediatric homozygous familial hypercholesterolemia
3个月前
已完结
Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study
3个月前
已完结
Epidermolysis bullosa
3个月前
已完结
皖公网安备34019202002308
